Glaxosmithkline Consumer Healthcare Holdings recalls Gaviscon Liquid Antacid Extra Strength, Cool Mint, 12 FL OZ (355 mL) single pack and twin pack, Distributed by: GSK Con…
- Recall date
- May 28, 2020
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-1325-2020
- FDA classification
- Class II
- Brand / firm
- Glaxosmithkline Consumer Healthcare Holdings
- Sold / distributed
- U.S.A. Nationwide
Why it was recalled
Labeling: Label lacks warning - Magnesium safety warning is not present on the Gaviscon bottle label.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Gaviscon Liquid Antacid Extra Strength, Cool Mint, 12 FL OZ (355 mL) single pack and twin pack, Distributed by: GSK Consumer Healthcare Warren, NJ 07059, NDC 0135-0095-41
Get recall alerts
Free email alert whenever Glaxosmithkline Consumer Healthcare Holdings has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Glaxosmithkline Consumer Healthcare Holdings